The increased uptake of DA observed in the NAc core and shell of SI rats in the current study and in the NAc core in a previous report (Yorgason em
While cetuximab has demonstrated activity in SCCHN, new agents and treatment strategies are needed that will provide both improved tolerability and efficacy. Future directions beyond cetuximab: inhibiting the ErbB family